Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)

(ADNI3 Trial)

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen by Ronald Peterson, MD, PHD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of Southern California

No Placebo Group

Trial Summary

What is the purpose of this trial?

Since its launch in 2004, the overarching aim of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has been realized in informing the design of therapeutic trials in AD. ADNI3 continues the previously funded ADNI-1, ADNI-GO, and ADNI-2 studies that have been combined public/private collaborations between academia and industry to determine the relationships between the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's disease (AD). The overall goal of the study is to continue to discover, optimize, standardize, and validate clinical trial measures and biomarkers used in AD research.

Research Team

Paul Aisen, MD

Principal Investigator

USC Alzheimer's Therapeutic Research Institute (ATRI)

Michael W. Weiner, MD

Principal Investigator

University of California, San Francisco

Ronald Peterson, MD, PHD

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

Participant with or without subjective memory complaints, verified by a study partner, beyond what one would expect for age

9 for 16 or more years of education

5 for 8-15 years of education

Treatment Details

Interventions

• None ()

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Columbia University New York, NY

New York University Medical Center New York, NY

University of British Columbia, Clinic for AD & Related Vancouver, Canada

Roper St. Francis Hospital Charleston, SC

Who Is Running the Clinical Trial?

University of Southern California

Lead Sponsor

Trials

956

Patients Recruited

1,609,000+

Northern California Institute of Research and Education

Collaborator

Trials

30

Patients Recruited

10,400+

National Institute on Aging (NIA)

Collaborator

Trials

1841

Patients Recruited

28,150,000+

Alzheimer's Therapeutic Research Institute

Collaborator

Trials

18

Patients Recruited

58,400+